Evolution of Relapse-Proficient Subclones Constrained by Collateral Sensitivity to Oncogene Overdose in Wnt-Driven Mammary Cancer

Ross R. Keller; Edward J. Gunther

doi:10.1016/j.celrep.2018.12.096

Evolution of Relapse-Proficient Subclones Constrained by Collateral Sensitivity to Oncogene Overdose in Wnt-Driven Mammary Cancer

Ross R. Keller, Edward J. Gunther

Research output: Contribution to journal › Article

2 Scopus citations

Abstract

Keller and Gunther show that Wnt-driven mammary cancers challenged with simulated targeted therapy (Wnt withdrawal) undergo clonal evolution, which stringently selects for mutations that restore a “just right” level of oncogenic signaling. Therefore, cancer relapses emerge from rare subclones that are encumbered by an untapped vulnerability to oncogene overdose.

Original language	English (US)
Pages (from-to)	893-905.e4
Journal	Cell Reports
Volume	26
Issue number	4
DOIs	https://doi.org/10.1016/j.celrep.2018.12.096
State	Published - Jan 22 2019

All Science Journal Classification (ASJC) codes

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1016/j.celrep.2018.12.096

Fingerprint Dive into the research topics of 'Evolution of Relapse-Proficient Subclones Constrained by Collateral Sensitivity to Oncogene Overdose in Wnt-Driven Mammary Cancer'. Together they form a unique fingerprint.

Cite this

Keller, R. R., & Gunther, E. J. (2019). Evolution of Relapse-Proficient Subclones Constrained by Collateral Sensitivity to Oncogene Overdose in Wnt-Driven Mammary Cancer. Cell Reports, 26(4), 893-905.e4. https://doi.org/10.1016/j.celrep.2018.12.096

@article{b4878f82b2cb4c11bfe68cbdd1281c0b,

title = "Evolution of Relapse-Proficient Subclones Constrained by Collateral Sensitivity to Oncogene Overdose in Wnt-Driven Mammary Cancer",

abstract = "Keller and Gunther show that Wnt-driven mammary cancers challenged with simulated targeted therapy (Wnt withdrawal) undergo clonal evolution, which stringently selects for mutations that restore a “just right” level of oncogenic signaling. Therefore, cancer relapses emerge from rare subclones that are encumbered by an untapped vulnerability to oncogene overdose.",

author = "Keller, {Ross R.} and Gunther, {Edward J.}",

year = "2019",

month = jan,

day = "22",

doi = "10.1016/j.celrep.2018.12.096",

language = "English (US)",

volume = "26",

pages = "893--905.e4",

journal = "Cell Reports",

issn = "2211-1247",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - Evolution of Relapse-Proficient Subclones Constrained by Collateral Sensitivity to Oncogene Overdose in Wnt-Driven Mammary Cancer

AU - Keller, Ross R.

AU - Gunther, Edward J.

PY - 2019/1/22

Y1 - 2019/1/22

N2 - Keller and Gunther show that Wnt-driven mammary cancers challenged with simulated targeted therapy (Wnt withdrawal) undergo clonal evolution, which stringently selects for mutations that restore a “just right” level of oncogenic signaling. Therefore, cancer relapses emerge from rare subclones that are encumbered by an untapped vulnerability to oncogene overdose.

AB - Keller and Gunther show that Wnt-driven mammary cancers challenged with simulated targeted therapy (Wnt withdrawal) undergo clonal evolution, which stringently selects for mutations that restore a “just right” level of oncogenic signaling. Therefore, cancer relapses emerge from rare subclones that are encumbered by an untapped vulnerability to oncogene overdose.

UR - http://www.scopus.com/inward/record.url?scp=85059735246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059735246&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.12.096

DO - 10.1016/j.celrep.2018.12.096

M3 - Article

C2 - 30673612

AN - SCOPUS:85059735246

VL - 26

SP - 893-905.e4

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 4

ER -